Reduced Incidence of Intraoperative Complications in a Multicenter Controlled Clinical Trial of Triamcinolone in Vitrectomy

Ophthalmology

Volumn 114, Issue 2, 2007, Pages

  Yamakiri, Keita ^a   Sakamoto, Taiji ^a   Noda, Yoshihiro ^b   Nakahara, Masaaki ^c   Ogino, Nobuchika ^d   Kubota, Toshiaki ^e   Yokoyama, Mitsunobu ^f   Furukawa, Mariko ^g   Sonoda, Yasushi ^h   Yamada, Tomomi ^b   Doi, Norihito ⁱ   Enaida, Hiroshi ^b   Hata, Yasuaki ^b   Ishibashi, Tatsuro ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Miyata Eye Hospital   (Japan)

^d Shinjo Eye Clinic   (Japan)

^e UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^f Kimura Eye and Int Med Hospital   (Japan)

^g Kamiiida Daiichi General Hospital   (Japan)

^h Amatatsu Hospital   (Japan)

ⁱ IMAMURA GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; EYE DROPS; TRIAMCINOLONE ACETONIDE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CILIARY DISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG USE; ENDOPHTHALMITIS; FEMALE; HOSPITAL; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE; INTRAOPERATIVE PERIOD; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT MONITORING; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA DEGENERATION; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA TEAR; SIDE EFFECT; VITRECTOMY; VITREOUS BODY; VITREOUS HEMORRHAGE;

EID: 33846488942     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.07.044     Document Type: Article

References (22)

1. Peyman G.A., Cheema R., Conway M.D., and Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 20 (2000) 554-555
2. Sakamoto T., Miyazaki M., Hisatomi T., et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240 (2002) 423-429
3. Sonoda K.H., Sakamoto T., Enaida H., et al. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 111 (2004) 226-230
4. Enaida H., Hata Y., Ueno A., et al. Visualization of the Cloquet canal during triamcinolone-assisted vitrectomy. Arch Ophthalmol 122 (2004) 1564-1565
5. Enaida H., Hata Y., Ueno A., et al. Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina 23 (2003) 764-770
6. Sonoda K.H., Enaida H., Ueno A., et al. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. Br J Ophthalmol 87 (2003) 1010-1014
7. Furino C., Micelli Ferrari T., Boscia F., et al. Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy. Retina 23 (2003) 771-776
8. Ikuno Y., Sayanagi K., Ohji M., et al. Vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Am J Ophthalmol 137 (2004) 719-724
9. Kimura H., Kuroda S., and Nagata M. Triamcinolone acetonide-assisted peeling of the internal limiting membrane. Am J Ophthalmol 137 (2004) 172-173
10. Shah G.K., Rosenblatt B.J., and Smith M. Internal limiting membrane peeling using triamcinolone acetonide: histopathologic confirmation. Am J Ophthalmol 138 (2004) 656-657
11. Tognetto D., Zenoni S., Sanguinetti G., et al. Staining of the internal limiting membrane with intravitreal triamcinolone acetonide. Retina 25 (2005) 462-467
12. Jonas J.B., Hayler J.K., Sofker A., and Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 131 (2001) 468-471
13. Moshfeghi D.M., Kaiser P.K., Scott I.U., et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136 (2003) 791-796
14. Smithen L.M., Ober M.D., Maranan L., and Spaide R.F. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138 (2004) 740-743
15. Singh I.P., Ahmad S.I., Yeh D., et al. Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am J Ophthalmol 138 (2004) 286-287
16. Michels R.G., Wilkinson C.P., and Rice T.A. Retinal Detachment (1990), St. Louis, Mosby 761-888
17. Oyakawa R.T., Schachat A.P., Michels R.G., and Rice T.A. Complications of vitreous surgery for diabetic retinopathy. I. Intraoperative complications. Ophthalmology 90 (1983) 517-521
18. Michels R.G. Vitrectomy for macular pucker. Ophthalmology 91 (1984) 1384-1388
19. Jonas J.B., Kreissig I., and Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 87 (2003) 24-27
20. Smithen L.M., Ober M.D., Maranan L., and Spaide R.F. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138 (2004) 740-743
21. Sakamoto T., Enaida H., Kubota T., et al. Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy. Am J Ophthalmol 138 (2004) 137-138
22. Aaberg Jr. T.M., Flynn Jr. H.W., Schiffman J., and Newton J. Nosocomial acute-onset postoperative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology 105 (1998) 1004-1010